6355 related articles for article (PubMed ID: 3142675)
21. Phase II trial of recombinant alpha-2b interferon in the treatment of metastatic skin melanoma.
Sertoli MR; Bernengo MG; Ardizzoni A; Brunetti I; Falcone A; Vidili MG; Cusimano MP; Appino A; Doveil G; Fortini C
Oncology; 1989; 46(2):96-8. PubMed ID: 2710482
[TBL] [Abstract][Full Text] [Related]
22. Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanoma.
Creagan ET; Ahmann DL; Long HJ; Frytak S; Sherwin SA; Chang MN
Cancer Treat Rep; 1987 Sep; 71(9):843-4. PubMed ID: 3113730
[TBL] [Abstract][Full Text] [Related]
23. A Southwest Oncology Group Phase I study of the sequential combination of recombinant interferon-gamma and recombinant interleukin-2 in patients with cancer.
Taylor CW; Chase EM; Whitehead RP; Rinehart JJ; Neidhart JA; Gonzalez R; Bunn PA; Hersh EM
J Immunother (1991); 1992 Apr; 11(3):176-83. PubMed ID: 1515422
[TBL] [Abstract][Full Text] [Related]
24. In vivo effects of combination treatment with recombinant interferon-gamma and -alpha in metastatic melanoma.
Osanto S; Jansen R; Naipal AM; Gratama JW; van Leeuwen A; Cleton FJ
Int J Cancer; 1989 Jun; 43(6):1001-6. PubMed ID: 2499552
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of metastatic kidney cancer with recombinant alpha-2 or gamma interferon. Results of 2 clinical phase II and III studies].
Otto U; Schneider A; Denkhaus H; Conrad S
Onkologie; 1988 Aug; 11(4):185-91. PubMed ID: 3141856
[TBL] [Abstract][Full Text] [Related]
26. Differential in vitro effects of recombinant alpha-interferon and recombinant gamma-interferon alone or in combination on the expression of melanoma-associated surface antigens.
Murray JL; Stuckey SE; Pillow JK; Rosenblum MG; Gutterman JU
J Biol Response Mod; 1988 Apr; 7(2):152-61. PubMed ID: 3129542
[TBL] [Abstract][Full Text] [Related]
27. Phase II study of recombinant leukocyte A interferon (IFN-rA) plus cimetidine in disseminated malignant melanoma.
Creagan ET; Ahmann DL; Green SJ; Long HJ; Frytak S; Itri LM
J Clin Oncol; 1985 Jul; 3(7):977-81. PubMed ID: 4020408
[TBL] [Abstract][Full Text] [Related]
28. Disseminated malignant melanoma and recombinant interferon: analysis of seven consecutive phase II investigations.
Creagan ET; Schaid DJ; Ahmann DL; Frytak S
J Invest Dermatol; 1990 Dec; 95(6 Suppl):188S-192S. PubMed ID: 2124246
[TBL] [Abstract][Full Text] [Related]
29. Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma.
Weiner LM; Moldofsky PJ; Gatenby RA; O'Dwyer J; O'Brien J; Litwin S; Comis RL
Cancer Res; 1988 May; 48(9):2568-73. PubMed ID: 3128400
[TBL] [Abstract][Full Text] [Related]
30. Interferon in combination with vinblastine in advanced malignant melanoma. A phase I-II study.
Gundersen S; Flokkmann A
Cancer; 1989 Oct; 64(8):1617-9. PubMed ID: 2790673
[TBL] [Abstract][Full Text] [Related]
31. Studies of interferons in the therapy of melanoma.
Kirkwood JM
Semin Oncol; 1991 Oct; 18(5 Suppl 7):83-90. PubMed ID: 1948134
[TBL] [Abstract][Full Text] [Related]
32. Treatment of metastatic malignant melanoma with recombinant interferon alpha 2.
Robinson WA; Mughal TI; Thomas MR; Johnson M; Spiegel RJ
Immunobiology; 1986 Sep; 172(3-5):275-82. PubMed ID: 3804370
[TBL] [Abstract][Full Text] [Related]
33. Phase II trial of recombinant human interleukin-2 and interferon-alpha-2a: implications for the treatment of patients with metastatic melanoma.
Eton O; Talpaz M; Lee KH; Rothberg JM; Brell JM; Benjamin RS
Cancer; 1996 Mar; 77(5):893-9. PubMed ID: 8608480
[TBL] [Abstract][Full Text] [Related]
34. [Human recombinant leukocyte interferon alpha-2-A in 22 cases of metastatic malignant melanoma].
Maral J; Steinberg M; Weil M; Chleq C; Khayat D; Banzet P; Jacquillat C
Presse Med; 1987 Jun; 16(21):1031-4. PubMed ID: 2955323
[TBL] [Abstract][Full Text] [Related]
35. [Antitumor effects of recombinant human leukocyte interferon (rIFN-alpha A) on human malignomas transplanted into nude mice].
Hashizume S
Gan To Kagaku Ryoho; 1985 Feb; 12(2):284-8. PubMed ID: 3970552
[TBL] [Abstract][Full Text] [Related]
36. Phase II trial of recombinant leukocyte A interferon in advanced malignant melanoma.
Elsässer-Beile U; Drees N; Neumann HA; Schöpf E
J Cancer Res Clin Oncol; 1987; 113(3):273-8. PubMed ID: 3584216
[TBL] [Abstract][Full Text] [Related]
37. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.
Lienard D; Ewalenko P; Delmotte JJ; Renard N; Lejeune FJ
J Clin Oncol; 1992 Jan; 10(1):52-60. PubMed ID: 1727926
[TBL] [Abstract][Full Text] [Related]
38. Phase II trial of lymphoblastoid interferon in metastatic malignant melanoma.
Goldberg RM; Ayoob M; Silgals R; Ahlgren JD; Neefe JR
Cancer Treat Rep; 1985; 69(7-8):813-6. PubMed ID: 4016791
[TBL] [Abstract][Full Text] [Related]
39. Concomitant administration of recombinant human interleukin-2 and recombinant interferon alpha-2A in cancer patients: a phase I study.
Lee KH; Talpaz M; Rothberg JM; Murray JL; Papadopoulos N; Plager C; Benjamin R; Levitt D; Gutterman J
J Clin Oncol; 1989 Nov; 7(11):1726-32. PubMed ID: 2809685
[TBL] [Abstract][Full Text] [Related]
40. Increased intracellular killing of bacteria in vitro by monocytes of patients with metastatic melanoma before and during treatment with interferon-gamma and interferon-alpha.
Osanto S; van den Barselaar MT; van Dissel JT
Eur J Cancer; 1991; 27(4):478-82. PubMed ID: 1827724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
